Reports that a quarter of New York patients who undergo cardiac catheterization likely received this invasive test unnecessarily have raised concerns for both patients and payers across the country. But when those questions arise, Creagh Milford, DO, MPH, associate medical director at Partners Health Care, and his colleagues are prepared to allay them with data that show that about 90% of catheterizations at Massachusetts General Hospital and its sister hospital Brigham and Women’s Hospital meet criteria for appropriateness.
That data and the confidence it inspires is a product of the hospital’s Queriable Patient Inference Dossier (QPID), which Milford described during a session at the HIMSS 2015 annual meeting. The QPID system is a software program that extracts data from patient records, medical literature, and relevant guidelines to help guide physicians and patients through the process of assessing the treatment options for a particular condition.
The physician still leads the process and makes the final decision, said Michael Zalis, MD, a radiologist and chief medical officer of QPID Health, a company created to commercialize the QPID platform. But the software cuts out some of the labor associated with culling relevant data from the patient’s medical record and highlights for the physician which patient data may be relevant to the decision. With these data in hand, the physician is guided through a decision tree based on the relevant clinical guidelines and professional consensus. At the end of the process, the physician and patient discuss a list of possible options graded based on their appropriateness.